Wuhu Huaren is a functional chemical research and development company, mainly engaged in the development of a series of nucleoside phosphoramidite monomers, nucleosides and nucleotides and their modifications, heterocyclic and carbohydrate compounds, and new-generation antiviral drug intermediates. Development, production and sales. Recently, Huadong Medicine plans to invest no more than 396 million yuan to acquire 60% equity of Huaren Technology and become its controlling shareholder by means of capital increase and transfer of shares.
This article is reprinted from: https://www.itjuzi.com/merger/9202
This site is for inclusion only, and the copyright belongs to the original author.